Displaying items by tag: oneal comprehensive cancer center

Treating blood disorders and cancers cannot be done alone. It requires the strong will of a patient, the support of family, and the compassion and expertise of a world-renowned health care team, like those with the O’Neal Comprehensive Cancer Center at UAB’s Bone Marrow Transplantation and Cell Therapy program.
Preclinical experiments show how to identify non-responding tumors and improve their response to immunotherapy, using two investigational new drugs that are permitted for human use. Physicians could immediately start investigational research in patients to test the effectiveness of this personalized approach.

Join UAB’s Dr. Mona Fouad to hear a discussion on implicit and explicit bias in the field of science and medicine. 

Because the beam of photons is so tightly focused, proton therapy has little effect on surrounding healthy tissue, making it especially beneficial for young patients.
The new grant links UAB researchers with colleagues at two other institutions to search for ways to advance therapies from bench to bedside.
The O’Neal Invests program funds UAB investigators starting new cancer-related projects to initiate key, preliminary work needed to enable competitive R01 applications from the NIH.

Blood and marrow transplantation strategies have changed significantly over the past four decades; but recipients still experience excess mortality that translates into 8.7 years of life lost, according to researchers in UAB’s Institute for Cancer Outcomes and Survivorship.

Limiting neuroinflammation may represent a promising new approach to treat neurological diseases driven by neuroinflammation, such as stroke, spinal cord injury and neuropathic pain.

This finding upends the long-held paradigm that priming during lung infections takes place only in the draining lymph nodes, and it will be key to developing more efficient vaccinations and therapies for respiratory challenges.

The drug Vismodegib, tested in a breast cancer model, is an inhibitor of hedgehog signaling, a form of cell communication manipulated by the tumor microenvironment.
Adaptive radiation therapy allows for more precise treatment by fine-tuning the treatment regimen based on up-to-date imaging.
The 14th annual Fiesta Ball, now happening for an entire week July 17-24, will have an online auction and participation from five local Mexican and Tex-Mex restaurants.
A small molecule inhibitor has been identified that reduces the growth of uveal melanoma, a rare and deadly cancer of the eye.

The largest coalition of biological and biomedical research associations in the United States, known as FASEB, advocates for the basic biomedical research community.

Elizabeth Brown, Ph.D., has received a $3.1 million grant from the National Cancer Institute to study epigenetic contribution to the excess risk of a precursor of multiple myeloma in African Americans.
The genetic counseling field has become an important component of medicine in the past decade. Alabama law now mandates all genetic counselors practicing in the state be licensed by fall of 2021.

The alliance will focus on boosting participation in clinical research within historically underrepresented patient groups. 

Gregory Friedman, M.D., has received a special grant to test various therapy combinations with a form of the herpes virus to improve anti-tumor immune response in children battling brain cancer.

Page 8 of 34